KR870700608A - 아미노-살리실산 유도체 및 제약 조성물 - Google Patents
아미노-살리실산 유도체 및 제약 조성물Info
- Publication number
- KR870700608A KR870700608A KR1019860700507A KR860700507A KR870700608A KR 870700608 A KR870700608 A KR 870700608A KR 1019860700507 A KR1019860700507 A KR 1019860700507A KR 860700507 A KR860700507 A KR 860700507A KR 870700608 A KR870700608 A KR 870700608A
- Authority
- KR
- South Korea
- Prior art keywords
- amino
- pharmaceutical compositions
- acid derivatives
- salicylic acid
- salicylic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- NBGAYCYFNGPNPV-UHFFFAOYSA-N 2-aminooxybenzoic acid Chemical class NOC1=CC=CC=C1C(O)=O NBGAYCYFNGPNPV-UHFFFAOYSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/56—Amides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
- C07H13/12—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by acids having the group -X-C(=X)-X-, or halides thereof, in which each X means nitrogen, oxygen, sulfur, selenium or tellurium, e.g. carbonic acid, carbamic acid
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT23799/84A IT1196348B (it) | 1984-11-29 | 1984-11-29 | Composti ad attivita'antiinfiammatoria |
| PCT/EP1985/000645 WO1986003199A1 (en) | 1984-11-29 | 1985-11-26 | Amino-salicylic acid derivatives and pharmaceutical compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR870700608A true KR870700608A (ko) | 1987-12-30 |
Family
ID=11210091
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019860700507A Ceased KR870700608A (ko) | 1984-11-29 | 1986-07-28 | 아미노-살리실산 유도체 및 제약 조성물 |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP0236329A1 (enExample) |
| JP (1) | JPS62501703A (enExample) |
| KR (1) | KR870700608A (enExample) |
| CN (1) | CN85109554A (enExample) |
| AU (1) | AU5231186A (enExample) |
| DK (1) | DK346486D0 (enExample) |
| ES (1) | ES8701717A1 (enExample) |
| GR (1) | GR852834B (enExample) |
| IT (1) | IT1196348B (enExample) |
| PT (1) | PT81566B (enExample) |
| WO (1) | WO1986003199A1 (enExample) |
| ZA (1) | ZA859035B (enExample) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9017710D0 (en) * | 1990-08-13 | 1990-09-26 | May & Baker Ltd | New compositions of matter |
| GB9017711D0 (en) * | 1990-08-13 | 1990-09-26 | May & Baker Ltd | New compositions of matter |
| IT1244873B (it) * | 1990-09-12 | 1994-09-12 | Depha Team Srl | Derivati dell'acido 5-aminosalicilico (5-asa) per la terapia delle infiammazioni croniche intestinali |
| US5366987A (en) * | 1991-08-22 | 1994-11-22 | Warner-Lambert Company | Isoxazolyl-substituted alkyl amide ACAT inhibitors |
| FR2738150B1 (fr) * | 1995-09-01 | 1997-10-31 | Synthelabo | Utilisation de la sulphasalazine et de ses metabolites pour la fabrication d'un medicament utile dans le traitement de l'insuffisance veineuse et des ulceres veineux |
| AU4149400A (en) * | 2000-04-19 | 2001-10-30 | Neurotech Co Ltd | Compounds, compositions and methods for preventing neurodegeneration in acute and chronic injuries in the central nervous system |
| US6573402B1 (en) | 2000-04-20 | 2003-06-03 | Neurotech Co., Ltd. | Compounds, compositions and methods for preventing neurodegeneration in acute and chronic injuries in the central nervous system |
| DE60114724T2 (de) * | 2000-07-18 | 2006-06-01 | Dainichiseika Color & Chemicals Mfg. Co., Ltd. | Blutflussverbesserer und Mittel zur Vorbeugung oder Heilung von Thrombose |
| EP1225449B1 (en) | 2001-01-19 | 2008-10-22 | Apex Biotechnology Corporation | Non-enzymatic disposable electrode strip comprising a surfactant for detecting uric acid or hemoglobin; method for producing the same and its use |
| KR20100107509A (ko) | 2001-09-14 | 2010-10-05 | 9222-9129 퀘벡 인코포레이티드 | 히스톤 데아세틸라아제의 억제제 |
| DK1551793T3 (en) | 2002-06-19 | 2016-04-25 | Gnt Pharma Co Ltd | Tetrafluorobenzyl derivatives and pharmaceutical compositions containing these for the prevention and treatment of acute and chronic neurodegenerative diseases of the central nervous system |
| KR100668111B1 (ko) | 2005-07-28 | 2007-01-12 | (주)에스에이치제약 | 강력한 항산화 효과를 가짐으로써 급성 및 퇴행성 뇌신경계질환의 예방 및 치료에 이용 가능한 신규물질인아미노살리실산 유도체와 그 염의 제조방법 |
| US8455470B2 (en) * | 2006-04-13 | 2013-06-04 | Neurotech Pharmaceuticals Co., Ltd | Pharmaceutical composition for treating or preventing degenerative and inflammatory diseases |
| CN100422721C (zh) * | 2006-05-26 | 2008-10-01 | 南京大学 | 一种利用糖基萘酚的铝离子检测方法 |
| WO2009054439A1 (ja) * | 2007-10-23 | 2009-04-30 | Institute Of Medicinal Molecular Design, Inc. | Pai-1産生抑制剤 |
| KR100852962B1 (ko) | 2007-11-12 | 2008-08-20 | 주식회사 뉴로테크 | 2-하이드록시-5-페닐알킬아미노벤조산 유도체 및 이의 염의제조방법 |
| US9085527B2 (en) | 2008-07-08 | 2015-07-21 | Catabasis Pharmaceuticals, Inc. | Fatty acid acylated salicylates and their uses |
| LT2315740T (lt) | 2008-07-08 | 2018-02-26 | Catabasis Pharmaceuticals, Inc. | Acetilinti riebalų rūgščių salicilatai ir jų panaudojimas |
| KR101204108B1 (ko) * | 2009-02-09 | 2012-11-22 | 주식회사 지엔티파마 | 5-벤질아미노살리실산 유도체 또는 이의 염의 의약 용도 |
| USRE46608E1 (en) | 2009-09-01 | 2017-11-14 | Catabasis Pharmaceuticals, Inc. | Fatty acid niacin conjugates and their uses |
| IN2012DN02661A (enExample) | 2009-09-01 | 2015-09-11 | Catabasis Pharmaceuticals Inc | |
| WO2013175357A2 (en) * | 2012-05-23 | 2013-11-28 | Mahesh Kandula | Compositions and methods for the treatment of inflammatory bowel disease |
| WO2014070859A1 (en) * | 2012-10-30 | 2014-05-08 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | Stat3 dimerization inhibitors |
| US20200206172A1 (en) * | 2018-12-28 | 2020-07-02 | Gnt Pharma Co., Ltd. | Compositions and methods for treating neurodegenerative disorders |
| CN111116395B (zh) * | 2019-12-27 | 2023-04-07 | 湖北工业大学 | 多碘代芳香酸类化合物及其在抗腺病毒7型中的应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR4546M (enExample) * | 1964-06-09 | 1966-11-02 | ||
| NL7008623A (enExample) * | 1969-06-25 | 1970-12-29 | ||
| JPS5640710B2 (enExample) * | 1973-01-18 | 1981-09-22 | ||
| JPS6056130B2 (ja) * | 1978-03-20 | 1985-12-09 | 久光製薬株式会社 | 新規なサリチル酸誘導体 |
| US4536346A (en) * | 1983-05-06 | 1985-08-20 | American Cyanamid Company | Aralkanamidophenyl compounds |
-
1984
- 1984-11-29 IT IT23799/84A patent/IT1196348B/it active
-
1985
- 1985-11-25 GR GR852834A patent/GR852834B/el unknown
- 1985-11-26 ZA ZA859035A patent/ZA859035B/xx unknown
- 1985-11-26 EP EP86900097A patent/EP0236329A1/en not_active Withdrawn
- 1985-11-26 WO PCT/EP1985/000645 patent/WO1986003199A1/en not_active Ceased
- 1985-11-26 JP JP61500163A patent/JPS62501703A/ja active Pending
- 1985-11-26 AU AU52311/86A patent/AU5231186A/en not_active Abandoned
- 1985-11-27 CN CN198585109554A patent/CN85109554A/zh active Pending
- 1985-11-27 PT PT81566A patent/PT81566B/pt unknown
- 1985-11-28 ES ES549359A patent/ES8701717A1/es not_active Expired
-
1986
- 1986-07-21 DK DK346486A patent/DK346486D0/da not_active Application Discontinuation
- 1986-07-28 KR KR1019860700507A patent/KR870700608A/ko not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| IT8423799A0 (it) | 1984-11-29 |
| WO1986003199A1 (en) | 1986-06-05 |
| DK346486A (da) | 1986-07-21 |
| IT1196348B (it) | 1988-11-16 |
| EP0236329A1 (en) | 1987-09-16 |
| PT81566B (en) | 1987-04-07 |
| GR852834B (enExample) | 1986-03-27 |
| DK346486D0 (da) | 1986-07-21 |
| ES549359A0 (es) | 1986-12-01 |
| AU5231186A (en) | 1986-06-18 |
| PT81566A (en) | 1985-12-01 |
| JPS62501703A (ja) | 1987-07-09 |
| ES8701717A1 (es) | 1986-12-01 |
| ZA859035B (en) | 1986-08-27 |
| CN85109554A (zh) | 1986-07-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR870700608A (ko) | 아미노-살리실산 유도체 및 제약 조성물 | |
| DK330287A (da) | Antiinflammatorisk forbindelse og farmaceutisk sammensaetning indeholdende samme | |
| NZ218588A (en) | Benzoic acid derivatives and pharmaceutical compositions | |
| NZ212499A (en) | Substituted benzamide derivatives and pharmaceutical compositions | |
| IT1214683B (it) | Composizioni farmaceutiche nasali | |
| FI892675A7 (fi) | 2,6-dihalogeenipyridiini-3-karboksyylihappojohdannaiset ja niiden valmistus | |
| KR870700618A (ko) | 크로모글릭산유도체와 그 제조방법 및 약학적 조성물 | |
| IT1209615B (it) | Composizione farmaceutica | |
| NZ210818A (en) | 8-alpha-acylaminoergoline derivatives and pharmaceutical compositions | |
| IL72157A (en) | 6-alpha-hydroxyethyl-2-substituted-2-penem-3-carboxylic acid derivatives and pharmaceutical compositions comprising them | |
| NZ216546A (en) | Glycerol derivatives and pharmaceutical compositions | |
| NZ224923A (en) | 2-methoxymethyl-penem-3-carboxylic acid derivatives and pharmaceutical compositions | |
| NZ215174A (en) | Barbituric acid derivatives and pharmaceutical compositions | |
| NZ212868A (en) | Phenylnonatetraenoic acid derivatives and pharmaceutical compositions and intermediates therefor | |
| DK99085D0 (da) | Farmaceutiske praeparater indeholdende a-vitaminsyrederivater | |
| NZ214284A (en) | Benzamide derivatives and pharmaceutical compositions | |
| NZ221018A (en) | 2-penem-3-carboxylic acid derivatives and pharmaceutical compositions | |
| DK317985D0 (da) | Aminoeburnancarboxylsyrederivater | |
| IT1216814B (it) | Composizioni farmaceutiche | |
| PH24338A (en) | Nitroapovincaminic acid derivatives and pharmaceutical compositions containing them | |
| NZ210817A (en) | N-hydroxy-alkoxynaphthalinalkanamine derivatives and pharmaceutical compositions | |
| IT1203737B (it) | Composizioni farmaceutiche comprendenti 3-amminopropossi-indoli | |
| IT8547703A1 (it) | Composizioni farmaceutiche comprendenti la bromocriptina | |
| NO850386L (no) | N-substituerte aminopropansulfonsyrederivater | |
| NZ211650A (en) | Eburnane derivatives and pharmaceutical compositions thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 19860728 |
|
| A201 | Request for examination | ||
| PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 19870203 Comment text: Request for Examination of Application Patent event code: PA02011R01I Patent event date: 19860728 Comment text: Patent Application |
|
| PG1501 | Laying open of application | ||
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 19890831 Patent event code: PE09021S01D |
|
| E601 | Decision to refuse application | ||
| PE0601 | Decision on rejection of patent |
Patent event date: 19891130 Comment text: Decision to Refuse Application Patent event code: PE06012S01D Patent event date: 19890831 Comment text: Notification of reason for refusal Patent event code: PE06011S01I |